10x Genomics
10x Genomics is a global leader in the spatial and single-cell genomics markets, recognized for platforms that enable researchers to analyze biological systems at unprecedented resolution. The company is a top vendor in spatial genomics, offering foundational platforms like Visium Spatial and Xenium In Situ. The Visium platform allows for whole transcriptome analysis of fresh frozen and FFPE tissue sections, maintaining the tissue’s morphological context. Its newer Visium HD Spatial Gene Expression Assay further empowers whole transcriptome analysis at single-cell resolution. Complementing this, the Xenium In Situ system maps RNA molecules with subcellular resolution using high-plex imaging. These technologies are crucial for dissecting cell-type differences, identifying novel biomarkers, and accelerating drug development across oncology, immunology, and neuroscience by providing quality data necessary for advanced biological insights and AI cell modeling.
Latest Market Research Report on Spatial Genomics Download PDF Brochure Now
Akoya Biosciences
Akoya Biosciences is a key player specializing in spatial biology solutions, with a strong focus on high-throughput, high-resolution spatial phenotyping, particularly for protein and RNA biomarker detection in tissue samples. Akoya’s core platforms, including the PhenoCycler-Fusion and PhenoImager, enable comprehensive spatial multiomic analysis, allowing scientists to visualize complex cellular interactions and microenvironments within tissues. Their technology is vital for advanced research in oncology and immunology, helping illuminate how tumors adapt and resist treatment. Recognized as a leading vendor, Akoya actively participates in strategic collaborations, such as licensing agreements with Thermo Fisher Scientific, to enhance the reach and application of its solutions. By providing precise and context-rich data, Akoya Biosciences drives advancements in translational research and personalized medicine, solidifying its essential role in the spatial omics landscape.
Bruker
Bruker Corporation, through its strategic expansion into the spatial omics field, particularly via Bruker Spatial Biology (incorporating NanoString’s technology), offers a comprehensive suite of solutions for spatial transcriptomics, proteomics, and genomics. Bruker provides advanced spatial molecular systems, including instruments, assays, software, and services. Key offerings leverage platforms such as the GeoMx® Digital Spatial Profiler (DSP) and the CosMx® Spatial Molecular Imager (SMI), which enable high-plex, multiomic, single-cell imaging. These tools are critical for translational research and discovery across fields like cancer research and immunology, allowing researchers to explore tissues with unprecedented resolution. Bruker is focused on empowering scientific breakthroughs by integrating cutting-edge platforms and offering multiomic services, reinforcing its position as a major provider of sophisticated analytical infrastructure in the life sciences market.
Bio-Techne Corporation
Bio-Techne is a top vendor in the spatial genomics market, providing instruments, reagents, and services essential for spatial analysis, reinforced by its strategic acquisition of Lunaphore Technologies. The company focuses on developing automated spatial omics multi-workflow systems designed to deliver flexibility and efficiency in analysis. Bio-Techne’s solutions help researchers map cellular environments, study disease mechanisms, and optimize biomarker development for clinical trial design in critical therapeutic areas, including oncology. By offering integrated and sophisticated tools, Bio-Techne simplifies complex spatial molecular analysis, providing essential support to academic institutions, large biopharma companies, and contract research organizations. This commitment to innovation and automation secures its role as a core technological provider driving the advancement and accessibility of spatial biology.
Illumina Inc.
Illumina is a global powerhouse in sequencing technology, integrating spatial genomics as a critical next step in genomic analysis. The company offers high-resolution, sequencing-based spatial technology designed to provide whole-transcriptome profiling in intact tissue sections, overcoming the limitations often associated with pre-defined gene panels in imaging-based methods. Utilizing its core sequencing expertise and flow cell technology, Illumina’s spatial solutions capture polyadenylated RNA transcripts on barcoded slides, which are then sequenced on high-throughput systems like the NovaSeq X Series. This process enables unbiased, whole-transcriptome depth combined with high spatial resolution and localized gene expression patterns at single-cell resolution. Illumina is dedicated to making high-resolution spatial analysis accessible for large-scale research projects, facilitating deeper insights into spatially defined cell states and tissue architecture globally.
Vizgen Corp.
Vizgen Corp. is a rapidly emerging leader in high-resolution spatial transcriptomics, known for its MERSCOPE Platform, which is powered by MERFISH (Multiplexed Error-Robust Fluorescence in situ Hybridization) technology. The MERSCOPE system delivers quantitative, single-cell spatial profiling of RNA, enabling researchers to map the expression of thousands of genes simultaneously at subcellular resolution within tissue samples. Vizgen’s technology is crucial for researchers seeking to understand complex biological systems by decoding molecular identities and assessing cell neighborhoods and interactions in detail. Positioned to capture significant market share, Vizgen provides advanced imaging and analysis software, empowering fundamental biological research, disease modeling, and drug discovery efforts with highly precise spatial molecular data.
NanoString Technologies, Inc.
NanoString Technologies, Inc., whose assets are now managed under Bruker Spatial Biology, was a pioneering force in the spatial genomics market through its flagship platforms: the GeoMx® Digital Spatial Profiler (DSP) and the CosMx® Spatial Molecular Imager (SMI). The GeoMx DSP facilitates targeted, high-plex protein and RNA whole-transcriptome analysis within specified regions of tissue. The CosMx SMI provides high-plex, multiomic, spatial single-cell imaging, essential for cell atlasing and biomarker discovery. These systems deliver subcellular resolution and are highly compatible with FFPE tissue samples, which are abundant in clinical research. The legacy platforms continue to be critical infrastructure, advancing spatial biology by allowing researchers to profile thousands of targets in a spatially resolved manner, driving translational and clinical research insights.
Standard BioTools
Standard BioTools, formerly known as Fluidigm Corporation, is listed among the major key players in the spatial omics solutions market. The company develops and provides technologies essential for studying life at the single-cell and spatial level, often utilizing its microfluidics expertise. Standard BioTools offers instruments and consumables that facilitate complex genomic and proteomic analyses. While broadly involved in life science research, its relevance in spatial genomics lies in providing integrated and automated tools that accelerate high-throughput sample processing and analysis, which are necessary inputs for many spatial omics workflows. By supporting the foundational aspects of sample analysis and quantification, Standard BioTools helps enable reliable and reproducible spatial discoveries for both academic and pharmaceutical customers.
S2 Genomics, Inc.
S2 Genomics, Inc. plays a vital, supportive role in the spatial genomics ecosystem by focusing on the critical initial step of automated tissue preparation. The company’s Singulator systems are designed to efficiently dissociate solid tissue samples—including fresh, frozen, and FFPE—into high-quality single-cell or single-nuclei suspensions. This high-quality, reproducible sample preparation is a prerequisite for many downstream spatial and single-cell sequencing applications. By automating tissue dissociation, S2 Genomics helps researchers overcome a significant manual bottleneck in the spatial genomics workflow, ensuring consistency and maximizing the viability of biological material for accurate spatial transcriptomics and gene expression profiling.
Dovetail Genomics
Dovetail Genomics, a brand under Cantata Bio, is a key company in the spatial genomics market specializing in advanced genome structure analysis. The company is primarily known for its proprietary proximity ligation technology, which is used to generate highly continuous, chromosome-scale genome assemblies. In the context of spatial omics, Dovetail’s technologies are instrumental for gaining insights into the three-dimensional organization of the genome and its transcriptional implications, which are crucial components of fully understanding cellular function in a spatial context. By offering tools for high-resolution genomic mapping and analysis, Dovetail Genomics supports researchers in integrating genomic structure data with spatial gene expression patterns, driving a deeper understanding of gene regulation and its spatial context within tissues.
Latest Market Research Report on Spatial Genomics Download PDF Brochure Now